Insider · CIK 0002009323
Edward C Fargis
Files at PRVA (Privia Health Group, Inc.). First filing Mar 12, 2025, latest Mar 10, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PRVA: Privia Health Group, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | PRVAsell Privia Health Group, Inc. | $215k 9,343 shares | -10% | +23% from low-12% from high | |
| 25Weak | PRVAsell Privia Health Group, Inc. | $120k 4,967 shares | -5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | PRVA Privia Health Group, Inc. | AGrant or award Common Stock, $0.01 par value per share | +28,268 | $0.00 | $0 | 111,979 | Mar 12, 2026 |
| Mar 6, 2026 | PRVA Privia Health Group, Inc. | SOpen-market sale Common Stock, $0.01 par value per share | -4,394 | $23.15 | $102k | 88,660 | Mar 10, 2026 |
| Mar 9, 2026 | PRVA Privia Health Group, Inc. | SOpen-market sale Common Stock, $0.01 par value per share | -4,949 | $22.84 | $113k | 83,711 | Mar 10, 2026 |
| Mar 10, 2025 | PRVA Privia Health Group, Inc. | SOpen-market sale Common Stock, $0.01 par value per share | -2,529 | $24.53 | $62k | 95,492 | Mar 12, 2025 |
| Mar 11, 2025 | PRVA Privia Health Group, Inc. | SOpen-market sale Common Stock, $0.01 par value per share | -2,438 | $23.88 | $58k | 93,054 | Mar 12, 2025 |
| Mar 5, 2025 | PRVA Privia Health Group, Inc. | AGrant or award Common Stock, $0.01 par value per share | +25,073 | $0.00 | $0 | 98,021 | Mar 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.